Ceramide C22:0 to sphingomyelin C26:0 ratio
Biomarker1 paper1 finding
- Humans1
Effects
1Cognitive impairment
mediatesin humans1
1 study
Cognitive impairment
mediatesin humans1
Ceramide C22:0 to sphingomyelin C26:0 ratio mediates cognitive impairment in humans (proportion mediated = -14.3%).
HumansHumidexmean-CI association
Associations between compound heat exposure and cognitive impairment and the potential mediating role of plasma sphingolipid metabolites: Evidence from a large-scale population cohort study · Environmental pollution (Barking, Essex : 1987) · 17 Sep 2026